{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T02:55:21Z","timestamp":1793933721415,"version":"4.8.0"},"reference-count":127,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T00:00:00Z","timestamp":1741737600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Aging Neurosci."],"abstract":"<jats:p>Parkinson\u2019s disease (PD) is a prevalent neurodegenerative disorder, best known for its motor symptoms such as resting tremor, muscle rigidity, and bradykinesia. However, autonomic dysfunction is an important non-motor aspect that often brings considerable discomfort and distress to both patients and their families. In this review, we summarize recent advances in understanding the pathophysiological mechanisms of autonomic dysfunction and explore its relationship with other clinical features. Our aim is to discover novel potential diagnostic and therapeutic strategies, alleviate patient suffering, and pave the way for future clinical and basic research.<\/jats:p>","DOI":"10.3389\/fnagi.2025.1468895","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T04:04:46Z","timestamp":1741752286000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":16,"title":["Advances in autonomic dysfunction research in Parkinson\u2019s disease"],"prefix":"10.3389","volume":"17","author":[{"given":"Hongjia","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Xing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhichao","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dewei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lifei","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulin","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunliang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,3,12]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3233\/jpd-202134","article-title":"The association between REM sleep behavior disorder and autonomic dysfunction in Parkinson\u2019s disease.","volume":"11","author":"Ashraf-ganjouei","year":"2021","journal-title":"J. Parkinson\u2019s Dis."},{"key":"B2","first-page":"928","article-title":"Probiotics and prebiotic fiber for constipation associated with Parkinson disease: An RCT.","volume":"17","author":"Barichella","year":"2016","journal-title":"Neurology"},{"key":"B3","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1002\/mds.27581","article-title":"Unraveling gut microbiota in Parkinson\u2019s disease and atypical parkinsonism.","volume":"34","author":"Barichella","year":"2018","journal-title":"Mov. Disord."},{"key":"B4","doi-asserted-by":"publisher","first-page":"988","DOI":"10.1016\/s0025-6196(12)62272-1","article-title":"The central autonomic network: Functional organization, dysfunction, and perspective.","volume":"68","author":"Benarroch","year":"1993","journal-title":"Mayo Clinic Proc."},{"key":"B5","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/s0140-6736(23)01419-8","article-title":"The epidemiology of Parkinson\u2019s disease.","volume":"403","author":"Ben-Shlomo","year":"2024","journal-title":"Lancet"},{"key":"B6","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1002\/mdc3.12456","article-title":"Sildenafil in the treatment of erectile dysfunction in Parkinson\u2019s disease.","volume":"4","author":"Bernard","year":"2016","journal-title":"Mov. Disord. Clin. Pract."},{"key":"B7","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1038\/s41583-021-00542-9","article-title":"Motor and non-motor circuit disturbances in early Parkinson disease: which happens first?","volume":"23","author":"Blesa","year":"2021","journal-title":"Nat. Rev. Neurosci."},{"key":"B8","doi-asserted-by":"publisher","first-page":"2284","DOI":"10.1016\/s0140-6736(21)00218-x","article-title":"Parkinson\u2019s disease.","volume":"397","author":"Bloem","year":"2021","journal-title":"Lancet"},{"key":"B9","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/s1474-4422(21)00377-x","article-title":"Cholinergic system changes in Parkinson\u2019s disease: Emerging therapeutic approaches.","volume":"21","author":"Bohnen","year":"2022","journal-title":"Lancet Neurol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"455","DOI":"10.3233\/jpd-202481","article-title":"The \u03b1-synuclein origin and connectome model (SOC Model) of Parkinson\u2019s disease: Explaining motor asymmetry, non-motor phenotypes, and cognitive decline.","volume":"11","author":"Borghammer","year":"2021","journal-title":"J. Parkinson\u2019s Dis."},{"key":"B11","doi-asserted-by":"publisher","first-page":"105557","DOI":"10.1016\/j.nbd.2021.105557","article-title":"Neuropathological evidence of body-first vs. brain-first Lewy body disease.","volume":"161","author":"Borghammer","year":"2021","journal-title":"Neurobiol. Dis."},{"key":"B12","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1038\/s41531-022-00436-2","article-title":"A postmortem study suggests a revision of the dual-hit hypothesis of Parkinson\u2019s disease.","volume":"8","author":"Borghammer","year":"2022","journal-title":"npj Parkinson\u2019s Dis."},{"key":"B13","doi-asserted-by":"publisher","first-page":"S281","DOI":"10.3233\/jpd-191721","article-title":"Brain-first versus gut-first Parkinson\u2019s disease: A hypothesis.","volume":"9","author":"Borghammer","year":"2019","journal-title":"J. Parkinson\u2019s Dis."},{"key":"B14","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1212\/WNL.0000000000004340","article-title":"Efficacy of single or combined midodrine and pyridostigmine in orthostatic hypotension.","volume":"89","author":"Byun","year":"2017","journal-title":"Neurology"},{"key":"B15","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41531-021-00191-w","article-title":"Early constipation predicts faster dementia onset in Parkinson\u2019s disease.","volume":"7","author":"Camacho","year":"2021","journal-title":"npj Parkinson\u2019s Dis."},{"key":"B16","doi-asserted-by":"publisher","first-page":"842498","DOI":"10.3389\/fnins.2022.842498","article-title":"Dysautonomia in Parkinson\u2019s disease: Impact of glucocerebrosidase gene mutations on cardiovascular autonomic control.","volume":"16","author":"Carandina","year":"2022","journal-title":"Front. Neurosci."},{"key":"B17","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.parkreldis.2019.05.038","article-title":"Small fiber neuropathy and phosphorylated alpha-synuclein in the skin of E46K-SNCA mutation carriers.","volume":"65","author":"Carmona-Abellan","year":"2019","journal-title":"Parkinsonism Relat. Disord."},{"key":"B18","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.3233\/jpd-223461","article-title":"Exploring the connection between the gut microbiome and Parkinson\u2019s disease symptom progression and pathology: Implications for supplementary treatment options.","volume":"12","author":"Chan","year":"2022","journal-title":"J. Parkinson\u2019s Dis."},{"key":"B19","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1007\/s10286-021-00771-z","article-title":"Thirty years of research on autonomic dysfunction, non-motor features, and endophenotypes in Parkinson disease.","volume":"31","author":"Chaudhuri","year":"2021","journal-title":"Clin. Autonomic Res."},{"key":"B20","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s40035-018-0118-8","article-title":"Age-dependent alpha-synuclein accumulation and aggregation in the colon of a transgenic mouse model of Parkinson\u2019s disease.","volume":"7","author":"Chen","year":"2018","journal-title":"Transl. Neurodegeneration"},{"key":"B21","doi-asserted-by":"publisher","first-page":"104700","DOI":"10.1016\/j.nbd.2019.104700","article-title":"Autonomic dysfunction in Parkinson\u2019s disease: Implications for pathophysiology, diagnosis, and treatment.","volume":"134","author":"Chen","year":"2020","journal-title":"Neurobiol. Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1002\/nau.24552","article-title":"Mirabegron for treatment of overactive bladder symptoms in patients with Parkinson\u2019s disease: A double-blind, randomized placebo-controlled trial (Parkinson\u2019s disease overactive bladder mirabegron. PaDoMi study).","volume":"40","author":"Cho","year":"2021","journal-title":"Neurourol. Urodyn."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1093\/brain\/awu084","article-title":"Uncovering the role of the insula in non-motor symptoms of Parkinson\u2019s disease.","volume":"137","author":"Christopher","year":"2014","journal-title":"Brain"},{"key":"B24","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1093\/brain\/awad388","article-title":"Nigrostriatal tau pathology in parkinsonism and Parkinson\u2019s disease.","volume":"147","author":"Chu","year":"2024","journal-title":"Brain"},{"key":"B25","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s10286-020-00745-7","article-title":"Gastrointestinal dysfunction in the synucleinopathies.","volume":"31","author":"Chung","year":"2020","journal-title":"Clin. Autonomic Res."},{"key":"B26","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.parkreldis.2018.10.028","article-title":"Association of SNCA variants with \u03b1-synuclein of gastric and colonic mucosa in Parkinson\u2019s disease.","volume":"61","author":"Chung","year":"2019","journal-title":"Parkinsonism Relat. Disord."},{"key":"B27","doi-asserted-by":"publisher","first-page":"101812","DOI":"10.1016\/j.arr.2022.101812","article-title":"Role of enteric glia and microbiota-gut-brain axis in parkinson disease pathogenesis.","volume":"84","author":"Claudino dos Santos","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"B28","doi-asserted-by":"publisher","first-page":"bhae270","DOI":"10.1093\/cercor\/bhae270","article-title":"Insular and limbic abnormal functional connectivity in early-stage Parkinson\u2019s disease patients with autonomic dysfunction.","volume":"34","author":"Conti","year":"2024","journal-title":"Cereb. Cortex"},{"key":"B29","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/S1567-4231(09)70054-1","article-title":"Sleep and autonomic nervous system dysfunction.","volume":"6","author":"Cortellia","year":"2005","journal-title":"Handb. Clin. Neurophysiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"1470","DOI":"10.1111\/ene.13752","article-title":"Professional occupation and the risk of Parkinson\u2019s disease.","volume":"25","author":"Darweesh","year":"2018","journal-title":"Eur. J. Neurol."},{"key":"B31","doi-asserted-by":"publisher","first-page":"296","DOI":"10.1002\/mds.26868","article-title":"Hypothalamic \u03b1-synuclein and its relation to weight loss and autonomic symptoms in Parkinson\u2019s disease.","volume":"32","author":"De Pablo-Fernandez","year":"2017","journal-title":"Mov. Disord."},{"key":"B32","doi-asserted-by":"publisher","first-page":"1620","DOI":"10.1002\/mdc3.13892","article-title":"Unraveling autonomic dysfunction in GBA-related Parkinson\u2019s disease.","volume":"10","author":"Devigili","year":"2023","journal-title":"Mov. Disord. Clin. Pract."},{"key":"B33","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1016\/j.jaci.2022.07.015","article-title":"Enteric nervous system and intestinal epithelial regulation of the gut-brain axis.","volume":"150","author":"Dowling","year":"2022","journal-title":"J. Allergy Clin. Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"63","DOI":"10.5664\/jcsm.10268","article-title":"Analysis of sleep, daytime sleepiness, and autonomic function in multiple system atrophy and Parkinson disease: A prospective study.","volume":"19","author":"Eckhardt","year":"2023","journal-title":"J. Clin. Sleep Med."},{"key":"B35","doi-asserted-by":"publisher","first-page":"249","DOI":"10.3390\/ijerph18010249","article-title":"Association between cardiac autonomic control and postural control in patients with Parkinson\u2019s disease.","volume":"18","author":"Espinoza-Vald\u00e9s","year":"2020","journal-title":"Int. J. Environ. Res. Public Health"},{"key":"B36","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1093\/brain\/awz111","article-title":"Evolution of prodromal Parkinson\u2019s disease and dementia with Lewy bodies: A prospective study.","volume":"142","author":"Fereshtehnejad","year":"2019","journal-title":"Brain"},{"key":"B37","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1002\/mdc3.12577","article-title":"Linaclotide and prucalopride for management of constipation in patients with Parkinsonism.","volume":"5","author":"Freitas","year":"2018","journal-title":"Mov. Disord. Clin. Pract."},{"key":"B38","doi-asserted-by":"publisher","first-page":"874349","DOI":"10.3389\/fnins.2022.874349","article-title":"Sleep and autonomic manifestations in Parkinson\u2019s disease complicated with probable rapid eye movement sleep behavior disorder.","volume":"16","author":"Fujita","year":"2022","journal-title":"Front. Neurosci."},{"key":"B39","doi-asserted-by":"publisher","first-page":"960","DOI":"10.1016\/j.juro.2011.04.071","article-title":"Botulinum toxin type A in patients with Parkinson\u2019s disease and refractory overactive bladder.","volume":"186","author":"Giannantoni","year":"2011","journal-title":"J. Urol."},{"key":"B40","doi-asserted-by":"publisher","first-page":"335","DOI":"10.3233\/jpd-230334","article-title":"The degree of cardiovascular autonomic dysfunction is not different in GBA-related and idiopathic Parkinson\u2019s disease patients: A case-control instrumental evaluation.","volume":"14","author":"Giannini","year":"2024","journal-title":"J. Parkinson\u2019s Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1016\/j.parkreldis.2008.12.009","article-title":"Olfactory dysfunction in pure autonomic failure: Implications for the pathogenesis of Lewy body diseases.","volume":"15","author":"Goldstein","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"B42","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1177\/1073858421990000","article-title":"Heart matters: Cardiac dysfunction and other autonomic changes in Parkinson\u2019s disease.","volume":"28","author":"Gon\u00e7alves","year":"2021","journal-title":"Neuroscientist"},{"key":"B43","doi-asserted-by":"publisher","first-page":"109436","DOI":"10.1016\/j.mehy.2019.109436","article-title":"Bile acid abnormality induced by intestinal dysbiosis might explain lipid metabolism in Parkinson\u2019s disease.","volume":"134","author":"Hasuike","year":"2020","journal-title":"Med. Hypotheses"},{"key":"B44","doi-asserted-by":"publisher","first-page":"57","DOI":"10.3233\/jpd-130259","article-title":"Droxidopa in patients with neurogenic orthostatic hypotension associated with Parkinson\u2019s disease (NOH306A).","volume":"4","author":"Hauser","year":"","journal-title":"J. Parkinson\u2019s Dis."},{"key":"B45","doi-asserted-by":"publisher","first-page":"646","DOI":"10.1002\/mds.26086","article-title":"Droxidopa for the short-term treatment of symptomatic neurogenic orthostatic hypotension in Parkinson\u2019s disease (nOH306B).","volume":"30","author":"Hauser","year":"","journal-title":"Mov. Disord."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1158986","DOI":"10.3389\/fcimb.2023.1158986","article-title":"The gastrointestinal tract and Parkinson\u2019s disease.","volume":"13","author":"Higinbotham","year":"2024","journal-title":"Front. Cell. Infection Microbiol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"106101","DOI":"10.1016\/j.parkreldis.2024.106101","article-title":"Brain-first vs. body-first Parkinson\u2019s disease: An update on recent evidence.","volume":"122","author":"Horsager","year":"2024","journal-title":"Parkinsonism Relat. Disord."},{"key":"B48","doi-asserted-by":"publisher","first-page":"fcad006","DOI":"10.1093\/braincomms\/fcad006","article-title":"Vagal cross-sectional area correlates with parasympathetic dysfunction in Parkinson\u2019s disease.","volume":"5","author":"Huckemann","year":"2023","journal-title":"Brain Commun."},{"key":"B49","doi-asserted-by":"publisher","first-page":"2346","DOI":"10.1002\/mds.28667","article-title":"\u03b1\u2212Synuclein deposition in sympathetic nerve fibers in genetic forms of Parkinson\u2019s disease.","volume":"36","author":"Isonaka","year":"2021","journal-title":"Mov. Disord."},{"key":"B50","doi-asserted-by":"publisher","first-page":"910","DOI":"10.1161\/hypertensionaha.118.12642","article-title":"Alpha-synuclein deposition within sympathetic noradrenergic neurons is associated with myocardial noradrenergic deficiency in neurogenic orthostatic hypotension.","volume":"73","author":"Isonaka","year":"2019","journal-title":"Hypertension"},{"key":"B51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2021\/2268651","article-title":"Correlation of dopaminergic denervation and the progression of autonomic dysfunctions in different clinical subtypes of Parkinson\u2019s disease.","volume":"2021","author":"Jeong","year":"2021","journal-title":"Parkinson\u2019s Dis."},{"key":"B52","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/j.parkreldis.2020.01.009","article-title":"Gastrointestinal symptoms are predictive of trajectories of cognitive functioning in de novo Parkinson\u2019s disease.","volume":"72","author":"Jones","year":"2020","journal-title":"Parkinsonism Relat. Disord."},{"key":"B53","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/0002-9343(93)90230-M","article-title":"Neurogenic orthostatic hypotension: A double-blind, placebo-controlled study with midodrine.","volume":"95","author":"Joseph","year":"1993","journal-title":"Am. J. Med."},{"key":"B54","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1007\/s10286-012-0158-6","article-title":"Olfactory dysfunction and parasympathetic dysautonomia in Parkinson\u2019s disease.","volume":"22","author":"Kang","year":"2012","journal-title":"Clin. Autonomic Res."},{"key":"B55","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1016\/j.neuron.2016.07.036","article-title":"High-throughput mapping of single-neuron projections by sequencing of barcoded RNA.","volume":"91","author":"Kebschull","year":"2016","journal-title":"Neuron"},{"key":"B56","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.jns.2016.01.020","article-title":"Orthostatic hypotension and cardiac sympathetic denervation in Parkinson disease patients with REM sleep behavioral disorder.","volume":"362","author":"Kim","year":"2016","journal-title":"J. Neurol. Sci."},{"key":"B57","doi-asserted-by":"publisher","first-page":"107086","DOI":"10.1016\/j.parkreldis.2024.107086","article-title":"Monoaminergic degeneration, cognition, and autonomic symptom trajectory in early Parkinson\u2019s disease.","volume":"127","author":"Kim","year":"2024","journal-title":"Parkinsonism Relat. Disord."},{"key":"B58","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.parkreldis.2010.06.006","article-title":"Use of botulinim toxin-A for the treatment of overactive bladder symptoms in patients with Parkinsons\u2019s disease.","volume":"16","author":"Kulaksizoglu","year":"2010","journal-title":"Parkinsonism Relat. Disord."},{"key":"B59","doi-asserted-by":"publisher","first-page":"525","DOI":"10.5603\/PJNNS.a2021.0040","article-title":"Cardiovascular dysautonomia and cognition in Parkinson\u2019s disease \u2014 A possible relationship.","volume":"55","author":"Kwa\u015bniak-Butowska","year":"2021","journal-title":"Neurol. Neurochirurgia Polska"},{"key":"B60","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1111\/ggi.14156","article-title":"Impact of motor subtype on non-motor symptoms and fall-related features in patients with early Parkinson\u2019s disease.","volume":"21","author":"Kwon","year":"","journal-title":"Geriatrics Gerontol. Int."},{"key":"B61","doi-asserted-by":"publisher","first-page":"11461","DOI":"10.1038\/s41598-022-15630-8","article-title":"Associations of cognitive dysfunction with motor and non-motor symptoms in patients with de novo Parkinson\u2019s disease.","volume":"12","author":"Kwon","year":"2022","journal-title":"Sci. Rep."},{"key":"B62","doi-asserted-by":"publisher","first-page":"5171","DOI":"10.1038\/s41598-021-84720-w","article-title":"Association of fall risk factors and non-motor symptoms in patients with early Parkinson\u2019s disease.","volume":"11","author":"Kwon","year":"","journal-title":"Sci. Rep."},{"key":"B63","doi-asserted-by":"publisher","first-page":"469","DOI":"10.5056\/jnm17141","article-title":"Relation of enteric \u03b1-Synuclein to gastrointestinal dysfunction in patients with Parkinson\u2019s disease and in neurologically intact subjects.","volume":"24","author":"Lee","year":"2018","journal-title":"J. Neurogastroenterol. Motility"},{"key":"B64","doi-asserted-by":"publisher","first-page":"59","DOI":"10.14802\/jmd.22045","article-title":"Association between gait and dysautonomia in patients with de novo Parkinson\u2019s Disease: Forward gait versus backward gait.","volume":"16","author":"Lee","year":"2023","journal-title":"J. Mov. Disord."},{"key":"B65","doi-asserted-by":"publisher","first-page":"773","DOI":"10.3390\/jpm11080773","article-title":"Personalised advanced therapies in Parkinson\u2019s disease: The role of non-motor symptoms profile.","volume":"11","author":"Leta","year":"","journal-title":"J. Pers. Med."},{"key":"B66","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1080\/14740338.2019.1681966","article-title":"Can therapeutic strategies prevent and manage dyskinesia in Parkinson\u2019s disease? An update.","volume":"18","author":"Leta","year":"2019","journal-title":"Exp. Opin. Drug Safety"},{"key":"B67","doi-asserted-by":"publisher","first-page":"1465","DOI":"10.1111\/ene.15734","article-title":"Gastrointestinal barriers to levodopa transport and absorption in Parkinson\u2019s disease.","volume":"30","author":"Leta","year":"2023","journal-title":"Eur. J. Neurol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.bbi.2021.07.026","article-title":"Neurogenic and anti-inflammatory effects of probiotics in Parkinson\u2019s disease: A systematic review of preclinical and clinical evidence.","volume":"98","author":"Leta","year":"","journal-title":"Brain Behav. Immunity"},{"key":"B69","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1212\/WNL.0000000000003838","article-title":"Predictive markers for early conversion of iRBD to neurodegenerative synucleinopathy diseases.","volume":"88","author":"Li","year":"2017","journal-title":"Neurology"},{"key":"B70","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1038\/s41420-024-01824-8","article-title":"Phosphorylated \u03b1-synuclein deposited in Schwann cells interacting with TLR2 mediates cell damage and induces Parkinson\u2019s disease autonomic dysfunction.","volume":"10","author":"Li","year":"2024","journal-title":"Cell Death Discov."},{"key":"B71","doi-asserted-by":"publisher","first-page":"5510","DOI":"10.1007\/s00415-022-11221-9","article-title":"Differential impact of individual autonomic domains on clinical outcomes in Parkinson\u2019s disease.","volume":"269","author":"Longardner","year":"2022","journal-title":"J. Neurol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/nature04767","article-title":"A putative flip\u2013flop switch for control of REM sleep.","volume":"441","author":"Lu","year":"2006","journal-title":"Nature"},{"key":"B73","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s00424-011-1054-y","article-title":"Brainstem mechanisms of paradoxical (REM) sleep generation.","volume":"463","author":"Luppi","year":"2011","journal-title":"Pfl\u00fcgers Archiv Eur. J. Physiol."},{"key":"B74","doi-asserted-by":"publisher","first-page":"101759","DOI":"10.1016\/j.smrv.2023.101759","article-title":"Sleep and wakefulness disturbances in Parkinson\u2019s disease: A meta-analysis on prevalence and clinical aspects of REM sleep behavior disorder, excessive daytime sleepiness and insomnia.","volume":"68","author":"Maggi","year":"2023","journal-title":"Sleep Med. Rev."},{"key":"B75","doi-asserted-by":"publisher","first-page":"804","DOI":"10.3390\/life11080804","article-title":"The impact of SNCA variations and its product alpha-synuclein on non-motor features of Parkinson\u2019s disease.","volume":"11","author":"Magistrelli","year":"2021","journal-title":"Life"},{"key":"B76","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1038\/s41586-019-1405-y","article-title":"Intestinal infection triggers Parkinson\u2019s disease-like symptoms in Pink1-\/- mice.","volume":"571","author":"Matheoud","year":"2019","journal-title":"Nature"},{"key":"B77","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1002\/mds.26632","article-title":"Orthostatic hypotension and cognitive impairment in Parkinson\u2019s disease: Causation or association?","volume":"31","author":"McDonald","year":"2016","journal-title":"Mov. Disord."},{"key":"B78","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1007\/s00415-021-10567-w","article-title":"Gastrointestinal dysfunction in Parkinson\u2019s disease: molecular pathology and implications of gut microbiome, probiotics, and fecal microbiota transplantation.","volume":"269","author":"Metta","year":"2021","journal-title":"J. Neurol."},{"key":"B79","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1007\/s10286-018-00584-7","article-title":"Autonomic dysfunction in Parkinson disease and animal models.","volume":"29","author":"Metzger","year":"2019","journal-title":"Clin. Auton. Res."},{"key":"B80","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/s0140-6736(23)01478-2","article-title":"The pathogenesis of Parkinson\u2019s disease.","volume":"403","author":"Morris","year":"2024","journal-title":"Lancet"},{"key":"B81","doi-asserted-by":"publisher","first-page":"3108","DOI":"10.1007\/s00415-019-09540-5","article-title":"Neocortical Lewy bodies are associated with impaired odor identification in community-dwelling elders without clinical PD.","volume":"266","author":"Nag","year":"2019","journal-title":"J. Neurol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"30","DOI":"10.5056\/jnm17105","article-title":"Gut microbiota dysfunction as reliable non-invasive early diagnostic biomarkers in the pathophysiology of Parkinson\u2019s disease: A critical review.","volume":"24","author":"Nair","year":"2018","journal-title":"J. Neurogastroenterol. Motility"},{"key":"B83","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/s2468-1253(18)30123-7","article-title":"Safety and efficacy of elobixibat for chronic constipation: results from a randomised, double-blind, placebo-controlled, phase 3 trial and an open-label, single-arm, phase 3 trial.","volume":"3","author":"Nakajima","year":"2018","journal-title":"Lancet Gastroenterol. Hepatol."},{"key":"B84","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1007\/s00415-009-5447-1","article-title":"Olfactory dysfunction and cardiovascular dysautonomia in Parkinson\u2019s disease.","volume":"257","author":"Oka","year":"2010","journal-title":"J. Neurol."},{"key":"B85","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1212\/WNL.0b013e3182574f28","article-title":"Placebo-controlled trial of lubiprostone for constipation associated with Parkinson disease.","volume":"78","author":"Ondo","year":"2012","journal-title":"Neurology"},{"key":"B86","doi-asserted-by":"publisher","first-page":"3444","DOI":"10.1007\/s00415-020-09985-z","article-title":"Early autonomic and cognitive dysfunction in PD, DLB and MSA: Blurring the boundaries between \u03b1-synucleinopathies.","volume":"267","author":"Palermo","year":"2020","journal-title":"J. Neurol."},{"key":"B87","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1002\/mds.27344","article-title":"Treatment of autonomic dysfunction in Parkinson disease and other synucleinopathies.","volume":"33","author":"Palma","year":"2018","journal-title":"Mov. Disord."},{"key":"B88","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1212\/wnl.0000000000206803","article-title":"Blood pressure and risk of dementia in Parkinson disease and multiple system atrophy.","volume":"100","author":"Palma","year":"2023","journal-title":"Neurology"},{"key":"B89","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.3233\/jpd-230173","article-title":"Non-pharmacological treatment of autonomic dysfunction in Parkinson\u2019s disease and other synucleinopathies.","volume":"14","author":"Palma","year":"2024","journal-title":"J. Parkinson\u2019s Dis."},{"key":"B90","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.ejphar.2017.05.042","article-title":"The gut-brain axis in Parkinson\u2019s disease: Possibilities for food-based therapies.","volume":"817","author":"Perez-Pardo","year":"2017","journal-title":"Eur. J. Pharmacol."},{"key":"B91","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.parkreldis.2018.07.005","article-title":"Mirabegron in patients with Parkinson disease and overactive bladder symptoms: A retrospective cohort.","volume":"57","author":"Peyronnet","year":"2018","journal-title":"Parkinsonism Relat. Disord."},{"key":"B92","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1007\/s13311-020-00897-4","article-title":"Autonomic dysfunction in Parkinson\u2019s disease.","volume":"17","author":"Pfeiffer","year":"2020","journal-title":"Neurotherapeutics"},{"key":"B93","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1016\/j.parkreldis.2019.06.003","article-title":"Dysbiosis of gut microbiota in a selected population of Parkinson\u2019s patients.","volume":"65","author":"Pietrucci","year":"2019","journal-title":"Parkinsonism Relat. Disord."},{"key":"B94","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1007\/s00702-024-02745-7","article-title":"Association between autonomic dysfunction with motor and non-motor symptoms in patients with Parkinson\u2019s disease.","volume":"131","author":"Qin","year":"2024","journal-title":"J. Neural Transmission"},{"key":"B95","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1080\/14656566.2020.1713097","article-title":"State-of-the-art pharmacotherapy for autonomic dysfunction in Parkinson\u2019s disease.","volume":"21","author":"Quarracino","year":"2020","journal-title":"Exp. Opin. Pharmacother."},{"key":"B96","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1161\/hypertensionaha.114.04225","article-title":"Efficacy of atomoxetine versus midodrine for the treatment of orthostatic hypotension in autonomic failure.","volume":"64","author":"Ramirez","year":"2014","journal-title":"Hypertension"},{"key":"B97","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1177\/08919887231204542","article-title":"The relationship between autonomic dysfunction and mood symptoms in De Novo Parkinson\u2019s disease patients over time.","volume":"37","author":"Ratajska","year":"2023","journal-title":"J. Geriatric Psychiatry Neurol."},{"key":"B98","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s00415-018-9104-4","article-title":"Cardiovascular autonomic neuropathy and falls in Parkinson disease: A prospective cohort study.","volume":"266","author":"Romagnolo","year":"2018","journal-title":"J. Neurol."},{"key":"B99","doi-asserted-by":"publisher","first-page":"e998","DOI":"10.1212\/wnl.0000000000201659","article-title":"Association between orthostatic hypotension and dementia in patients with Parkinson disease and multiple system atrophy.","volume":"100","author":"Ruiz-Barrio","year":"2023","journal-title":"Neurology"},{"key":"B100","doi-asserted-by":"publisher","first-page":"108959","DOI":"10.1016\/j.neuropharm.2022.108959","article-title":"New approaches to treatments for sleep, pain and autonomic failure in Parkinson\u2019s disease - Pharmacological therapies.","volume":"208","author":"Rukavina","year":"2022","journal-title":"Neuropharmacology"},{"key":"B101","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1038\/nrn.2017.62","article-title":"Non-motor features of Parkinson disease.","volume":"18","author":"Schapira","year":"2017","journal-title":"Nat. Rev. Neurosci."},{"key":"B102","doi-asserted-by":"publisher","first-page":"1543","DOI":"10.1002\/mds.21428","article-title":"Nonpharmacological treatment, fludrocortisone, and domperidone for orthostatic hypotension in Parkinson\u2019s disease.","volume":"22","author":"Schoffer","year":"2007","journal-title":"Mov. Disord."},{"key":"B103","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1111\/ene.13260","article-title":"Pyridostigmine bromide versus fludrocortisone in the treatment of orthostatic hypotension in Parkinson\u2019s disease \u2013 A randomized controlled trial.","volume":"24","author":"Schreglmann","year":"2017","journal-title":"Eur. J. Neurol."},{"key":"B104","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1111\/bpa.12168","article-title":"The brainstem pathologies of Parkinson\u2019s disease and dementia with lewy bodies.","volume":"25","author":"Seidel","year":"2014","journal-title":"Brain Pathol."},{"key":"B105","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/mds.27602","article-title":"Update on treatments for nonmotor symptoms of Parkinson\u2019s disease\u2014An evidence-based medicine review.","volume":"34","author":"Seppi","year":"2019","journal-title":"Mov. Disord."},{"key":"B106","doi-asserted-by":"publisher","first-page":"1099","DOI":"10.1038\/s41593-019-0423-2","article-title":"Lewy pathology in Parkinson\u2019s disease consists of crowded organelles and lipid membranes.","volume":"22","author":"Shahmoradian","year":"2019","journal-title":"Nat. Neurosci."},{"key":"B107","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1161\/hypertensionaha.107.089961","article-title":"Norepinephrine transporter blockade with atomoxetine induces hypertension in patients with impaired autonomic function.","volume":"50","author":"Shibao","year":"2007","journal-title":"Hypertension"},{"key":"B108","doi-asserted-by":"publisher","first-page":"1059","DOI":"10.3233\/jpd-213075","article-title":"Autonomic and depression symptoms in Parkinson\u2019s disease: Clinical evidence for overlapping physiology.","volume":"12","author":"Sklerov","year":"2022","journal-title":"J. Parkinson\u2019s Dis."},{"key":"B109","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1007\/s10286-020-00672-7","article-title":"Longitudinal change in autonomic symptoms predicts activities of daily living and depression in Parkinson\u2019s disease.","volume":"30","author":"Sklerov","year":"2020","journal-title":"Clin. Autonomic Res."},{"key":"B110","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s10286-016-0363-9","article-title":"Clinical benefit of midodrine hydrochloride in symptomatic orthostatic hypotension: A phase 4, double-blind, placebo-controlled, randomized, tilt-table study.","volume":"26","author":"Smith","year":"2016","journal-title":"Clin. Autonomic Res."},{"key":"B111","doi-asserted-by":"publisher","first-page":"1155669","DOI":"10.3389\/fneur.2023.1155669","article-title":"The longitudinal progression of autonomic dysfunction in Parkinson\u2019s disease: A 7-year study.","volume":"14","author":"Stewart","year":"2023","journal-title":"Front. Neurol."},{"key":"B112","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1007\/s00702-016-1667-6","article-title":"Parkinson\u2019s: A syndrome rather than a disease?","volume":"124","author":"Titova","year":"2016","journal-title":"J. Neural Transmission"},{"key":"B113","doi-asserted-by":"publisher","first-page":"e0247443","DOI":"10.1371\/journal.pone.0247443","article-title":"Associations between probable REM sleep behavior disorder, olfactory disturbance, and clinical symptoms in Parkinson\u2019s disease: A multicenter cross-sectional study.","volume":"16","author":"Toft","year":"2021","journal-title":"PLoS One"},{"key":"B114","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/s1474-4422(21)00030-2","article-title":"Challenges in the diagnosis of Parkinson\u2019s disease.","volume":"20","author":"Tolosa","year":"2021","journal-title":"Lancet Neurol."},{"key":"B115","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1186\/s12883-018-1151-z","article-title":"Urological dysfunctions in patients with Parkinson\u2019s disease: Clues from clinical and non-invasive urological assessment.","volume":"18","author":"Valentino","year":"2018","journal-title":"BMC Neurol."},{"key":"B116","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1007\/s00415-020-09785-5","article-title":"Autonomic failure in Parkinson\u2019s disease is associated with striatal dopamine deficiencies.","volume":"267","author":"van Deursen","year":"2020","journal-title":"J. Neurol."},{"key":"B117","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1002\/ana.24430","article-title":"\u03b1\u2212synuclein pathology accumulates in sacral spinal visceral sensory pathways.","volume":"78","author":"VanderHorst","year":"2015","journal-title":"Ann. Neurol."},{"key":"B118","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1002\/mds.27447","article-title":"Projections of prevalence, lifetime risk, and life expectancy of Parkinson\u2019s disease (2010-2030) in France.","volume":"33","author":"Wanneveich","year":"2018","journal-title":"Mov. Disord."},{"key":"B119","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1038\/s41531-022-00295-x","article-title":"Gastrointestinal involvement in Parkinson\u2019s disease: Pathophysiology, diagnosis, and management.","volume":"8","author":"Warnecke","year":"2022","journal-title":"npj Parkinson\u2019s Dis."},{"key":"B120","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1002\/acn3.51301","article-title":"Peripheral synucleinopathy in Parkinson disease with LRRK2 G2385R variants.","volume":"8","author":"Yang","year":"2021","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"B121","doi-asserted-by":"publisher","first-page":"5064","DOI":"10.1007\/s00415-024-12332-1","article-title":"Parkinson\u2019s disease with hyposmia and dysautonomia: Does it represent a distinct subtype?","volume":"271","author":"Yoon","year":"2024","journal-title":"J. Neurol."},{"key":"B122","doi-asserted-by":"publisher","first-page":"3786","DOI":"10.3390\/jcm9113786","article-title":"Association of postural instability with autonomic dysfunction in early Parkinson\u2019s disease.","volume":"9","author":"You","year":"2020","journal-title":"J. Clin. Med."},{"key":"B123","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1002\/mds.21243","article-title":"Macrogol for the treatment of constipation in Parkinson\u2019s disease. A randomized placebo-controlled study.","volume":"22","author":"Zangaglia","year":"2007","journal-title":"Mov. Disord."},{"key":"B124","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.parkreldis.2015.02.025","article-title":"Randomized, controlled pilot trial of solifenacin succinate for overactive bladder in Parkinson\u2019s disease.","volume":"21","author":"Zesiewicz","year":"2015","journal-title":"Parkinsonism Relat. Disord."},{"key":"B125","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1186\/s12883-022-02651-z","article-title":"Subthalamic nucleus-deep brain stimulation improves autonomic dysfunctions in Parkinson\u2019s disease.","volume":"22","author":"Zhang","year":"2022","journal-title":"BMC Neurol."},{"key":"B126","doi-asserted-by":"publisher","first-page":"1253874","DOI":"10.3389\/fneur.2023.1253874","article-title":"Acupuncture for Parkinson\u2019s disease-related constipation: Current evidence and perspectives.","volume":"14","author":"Zhang","year":"2023","journal-title":"Front. Neurol."},{"key":"B127","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1038\/s41531-023-00556-3","article-title":"Two distinct trajectories of clinical and neurodegeneration events in Parkinson\u2019s disease.","volume":"9","author":"Zhou","year":"2023","journal-title":"npj Parkinson\u2019s Dis."}],"container-title":["Frontiers in Aging Neuroscience"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2025.1468895\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T04:04:50Z","timestamp":1741752290000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnagi.2025.1468895\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,12]]},"references-count":127,"alternative-id":["10.3389\/fnagi.2025.1468895"],"URL":"https:\/\/doi.org\/10.3389\/fnagi.2025.1468895","relation":{},"ISSN":["1663-4365"],"issn-type":[{"value":"1663-4365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,12]]},"article-number":"1468895"}}